Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Cash Exit Payment

21 Oct 2020 16:42

RNS Number : 8343C
Highbridge Tactical Credit Fund Ltd
21 October 2020
Β 

21 October 2020

Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT OR ANY COPY OF IT. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.

Β 

Highbridge Tactical Credit Fund Limited

(the "Company")

Β 

Receipt of Shares in the Tactical Credit Fund and Fifth Cash Exit Payments

Β 

Further to the Company's circulars to Shareholders dated 31 July 2019 and 28 August 2019, the Company has received confirmation from Highbridge that it is to receive its fifth dividend-in-kind distribution of approximately Β£0.91m of new shares in TCF Feeder. This distribution represents approximately 23% of the remaining assets of the HMS Master Fund attributable to the Continuation Portfolio.

Β 

Further announcements will be made when further distributions are received. The Company will continue to be a shareholder of the Highbridge Multi-Strategy Fund Corporation (HCC) until all of the assets of the HMS Master Fund have been liquidated.

Β 

Fifth Cash Distribution

Β 

The Company has received Β£3,223,235 from Highbridge in connection with realisation of assets comprised in the Initial Redemption Portfolio (created following the Initial Cash Exit Offer) and the Redemption Portfolio (created following the Subsequent Cash Exit Offer). This amount represents approximately 23% of the remaining assets of the HMS Master Fund attributable to former shareholders of the Company who redeemed Shares pursuant to the Initial Cash Exit Offer and/or the Subsequent Cash Exit Offer ("2019 Cash Exit Offers" and "Multi-Strat Creditors" as applicable).

Β 

Accordingly, on or around 30 October 2020, approximately Β£3,212,000 is expected to be paid to Multi-Strat Creditors, equating to Β£0.039 per Share in respect of the 2019 Cash Exit Offers.

Β 

Multi-Strat Creditors are reminded that following this distribution they will receive future redemption proceeds as a number of cash payments following receipt by the Company of the redemption proceeds from HCC, and further announcements will be made when anyΒ cash payment is to be made following the realisation of any other assets comprised in the Redemption Portfolio.

Β 

Β 

For further information please contact:

Β 

Praxis Fund Services Limited

Company Secretary

Tel: +44 (0) 1481 737 600

LEI:Β 213800397SYHLYFH5961

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCBUBDGGSDDGGB
Date   Source Headline
20th Jul 20155:30 pmRNSTransaction in Own Shares
17th Jul 20155:30 pmRNSTransaction in Own Shares
16th Jul 20155:20 pmRNSSuccession Planning Update
16th Jul 20155:15 pmRNSTransaction in Own Shares
15th Jul 20155:20 pmRNSTransaction in Own Shares
15th Jul 20153:45 pmRNSNet Asset Value(s)
14th Jul 20155:10 pmRNSTransaction in Own Shares
14th Jul 20155:00 pmRNSHolding(s) in Company
13th Jul 20155:45 pmRNSTransaction in Own Shares
10th Jul 20155:45 pmRNSTransaction in Own Shares
9th Jul 20155:45 pmRNSTransaction in Own Shares
8th Jul 20156:30 pmRNSTransaction in Own Shares
8th Jul 20154:50 pmRNSNet Asset Value(s)
7th Jul 20156:00 pmRNSTransaction in Own Shares
3rd Jul 20155:40 pmRNSTransaction in Own Shares
3rd Jul 20154:15 pmRNSNet Asset Value(s)
2nd Jul 20155:30 pmRNSTransaction in Own Shares
1st Jul 20155:05 pmRNSConversion Between Share Classes
1st Jul 20152:32 pmRNSShare Buy-Back Engagement Extension
1st Jul 20152:30 pmRNSDerogation from the Model Code
1st Jul 20152:15 pmRNSNet Asset Value(s)
1st Jul 20159:30 amRNSTotal Voting Rights
26th Jun 20155:00 pmRNSTransaction in Own Shares
24th Jun 20152:45 pmRNSNet Asset Value(s)
22nd Jun 20155:15 pmRNSNet Asset Value(s)
18th Jun 20157:00 amRNSMonthly Performance Review
17th Jun 20154:00 pmRNSNet Asset Value(s)
16th Jun 20155:20 pmRNSTransaction in Own Shares
15th Jun 20155:00 pmRNSDirector's Other Directorship
12th Jun 20155:40 pmRNSTransaction in Own Shares
11th Jun 20155:30 pmRNSHolding(s) in Company
10th Jun 20152:30 pmRNSNet Asset Value(s)
4th Jun 20155:40 pmRNSTransaction in Own Shares
4th Jun 20157:00 amRNSAppointment of Non-Executive Director
3rd Jun 20156:00 pmRNSConversion Between Share Classes
3rd Jun 20154:15 pmRNSNet Asset Value(s)
29th May 20155:30 pmRNSTotal Voting Rights
28th May 20155:20 pmRNSNet Asset Value(s)
28th May 20155:00 pmRNSNet Asset Value(s)
21st May 20152:30 pmRNSMonthly Performance Review
20th May 20155:40 pmRNSTransaction in Own Shares
20th May 20152:30 pmRNSNet Asset Value(s)
15th May 20155:45 pmRNSTransaction in Own Shares
13th May 20155:00 pmRNSDirector's Other Directorship
13th May 20155:00 pmRNSNet Asset Value(s)
6th May 20154:30 pmRNSNet Asset Value(s)
5th May 20153:30 pmRNSConversion Between Share Classes
1st May 201510:00 amRNSTotal Voting Rights
29th Apr 20154:00 pmRNSNet Asset Value(s)
23rd Apr 20155:15 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.